Searching News Database: proton pump inhibitor
HSMN NewsFeed - 8 Jun 2018
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
European Commission Approves Prolia(R) (denosumab) for Patients With Glucocorticoid-Induced Osteoporosis
HSMN NewsFeed - 8 Nov 2017
New Clinical Data and Insurance Coverage Support Mederi's Stretta Therapy for GERD
New Clinical Data and Insurance Coverage Support Mederi's Stretta Therapy for GERD
HSMN NewsFeed - 24 Oct 2017
Stretta Therapy 15-Year Data Shows Long-Term Efficacy of Non-Surgical GERD Treatment
Stretta Therapy 15-Year Data Shows Long-Term Efficacy of Non-Surgical GERD Treatment
HSMN NewsFeed - 1 Jun 2015
POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEO
HSMN NewsFeed - 19 Nov 2013
Horizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO(R) and Provides 2014 Guidance
Horizon Pharma Announces Agreement to Acquire U.S. Rights to VIMOVO(R) and Provides 2014 Guidance
HSMN NewsFeed - 22 Mar 2012
POZEN Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of PA32540
POZEN Announces Positive Top-Line Results from Two Pivotal Phase 3 Studies of PA32540
HSMN NewsFeed - 26 Jan 2011
Bristol-Myers Squibb and sanofi-aventis Announce U.S. FDA Decision to Grant Pediatric Exclusivity For PLAVIX
Bristol-Myers Squibb and sanofi-aventis Announce U.S. FDA Decision to Grant Pediatric Exclusivity For PLAVIX
HSMN NewsFeed - 3 May 2010
FDA Approved VIMOVO(TM) for Arthritis Patients at Risk of Developing NSAID-Associated Gastric Ulcers
FDA Approved VIMOVO(TM) for Arthritis Patients at Risk of Developing NSAID-Associated Gastric Ulcers
HSMN NewsFeed - 22 Mar 2010
Given Imaging Signs Definitive Agreement to Acquire Sierra Scientific Instruments
Given Imaging Signs Definitive Agreement to Acquire Sierra Scientific Instruments
HSMN NewsFeed - 1 Mar 2010
AstraZeneca Exercises Option to Acquire Merck's Interest in Partnership Products
AstraZeneca Exercises Option to Acquire Merck's Interest in Partnership Products
HSMN NewsFeed - 1 Dec 2009
FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn
FDA Approves ZEGERID OTC(TM) for Over-the-Counter Treatment of Frequent Heartburn
HSMN NewsFeed - 14 Sep 2009
POZEN Names Elizabeth A. Cermak as Executive Vice President, Chief Commercial Officer
POZEN Names Elizabeth A. Cermak as Executive Vice President, Chief Commercial Officer
HSMN NewsFeed - 12 May 2009
AstraZeneca Secures Approval for Nexium (esomeprazole) In Peptic Ulcer Bleeding
AstraZeneca Secures Approval for Nexium (esomeprazole) In Peptic Ulcer Bleeding
HSMN NewsFeed - 4 May 2009
AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
AstraZeneca Submits NDA for Low Dose Aspirin/Esomeprazole Combination Product
HSMN NewsFeed - 23 Feb 2009
KAPIDEX(TM) (dexlansoprazole) delayed release capsules Now Available for the Treatment of GERD
KAPIDEX(TM) (dexlansoprazole) delayed release capsules Now Available for the Treatment of GERD
HSMN NewsFeed - 31 Jan 2009
FDA Approves KAPIDEX(TM) (Dexlansoprazole) Delayed Release Capsules for the Treatment of GERD
FDA Approves KAPIDEX(TM) (Dexlansoprazole) Delayed Release Capsules for the Treatment of GERD
HSMN NewsFeed - 29 Jan 2009
POZEN Informed by FDA That Endoscopic Gastric Ulcer Incidence Continues to Be an Acceptable Primary Endpoint
POZEN Informed by FDA That Endoscopic Gastric Ulcer Incidence Continues to Be an Acceptable Primary Endpoint
HSMN NewsFeed - 19 Dec 2008
AstraZeneca Submits sNDA for NEXIUM(R) for the Short-Term Treatment of GERD in Infants 0 to 1 Year Old
AstraZeneca Submits sNDA for NEXIUM(R) for the Short-Term Treatment of GERD in Infants 0 to 1 Year Old
HSMN NewsFeed - 22 Jul 2008
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products
Santarus and Depomed Announce U.S. Promotion Agreement for GLUMETZA Prescription Products
HSMN NewsFeed - 28 May 2008
Santarus Announces Development Program for New ZEGERID Prescription Product
Santarus Announces Development Program for New ZEGERID Prescription Product
HSMN NewsFeed - 15 Apr 2008
Santarus Provides Termination Notice to Otsuka America Pharmaceutical for ZEGERID Co-Promotion Agreement
Santarus Provides Termination Notice to Otsuka America Pharmaceutical for ZEGERID Co-Promotion Agreement
HSMN NewsFeed - 11 Mar 2008
Santarus Announces Submission of New Drug Application by Schering-Plough for ZEGERID Branded OTC Product
Santarus Announces Submission of New Drug Application by Schering-Plough for ZEGERID Branded OTC Product
HSMN NewsFeed - 19 Feb 2008
Santarus Announces Launch of ZEGERID Products by GlaxoSmithKline in Puerto Rico and U.S. Virgin Islands
Santarus Announces Launch of ZEGERID Products by GlaxoSmithKline in Puerto Rico and U.S. Virgin Islands
HSMN NewsFeed - 15 Nov 2007
Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension
HSMN NewsFeed - 8 Nov 2007
FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
FDA Approves New SPRYCEL(R) (Dasatinib) Product Labeling for Patients with Chronic-Phase CML
HSMN NewsFeed - 5 Oct 2007
POZEN Plans to Submit Response to Approvable Letter For Trexima(TM) Within the Next Ten Days
POZEN Plans to Submit Response to Approvable Letter For Trexima(TM) Within the Next Ten Days
HSMN NewsFeed - 27 Aug 2007
Santarus Announces Co-Promotion Agreement for Fleet Phospho-soda EZ-Prep System
Santarus Announces Co-Promotion Agreement for Fleet Phospho-soda EZ-Prep System
HSMN NewsFeed - 7 Aug 2007
Santarus Receives Notice of Paragraph IV Certification Against Patents for ZEGERID Capsules
Santarus Receives Notice of Paragraph IV Certification Against Patents for ZEGERID Capsules
HSMN NewsFeed - 2 Aug 2007
Teva Announces Approval of Generic Protonix(R) Delayed Release Tablets, 20 mg and 40 mg
Teva Announces Approval of Generic Protonix(R) Delayed Release Tablets, 20 mg and 40 mg
HSMN NewsFeed - 16 Feb 2007
Anti-HIV Medication PREZISTA(TM) Receives Conditional Marketing Authorisation in the European Union
Anti-HIV Medication PREZISTA(TM) Receives Conditional Marketing Authorisation in the European Union
HSMN NewsFeed - 21 Nov 2006
Santarus Announces Effective Date of OTC License Agreement with Schering-Plough
Santarus Announces Effective Date of OTC License Agreement with Schering-Plough
HSMN NewsFeed - 3 Nov 2006
Santarus and inVentiv Health Announce Agreement to Add Representatives to Santarus' ZEGERID Sales Team
Santarus and inVentiv Health Announce Agreement to Add Representatives to Santarus' ZEGERID Sales Team
HSMN NewsFeed - 18 Oct 2006
Santarus Licenses OTC Rights to Lower Dosage Immediate-Release ZEGERID Products to Schering-Plough
Santarus Licenses OTC Rights to Lower Dosage Immediate-Release ZEGERID Products to Schering-Plough
HSMN NewsFeed - 22 May 2006
Study Investigates NEXIUM(R) Benefits Patients With Zollinger-Ellison Syndrome
Study Investigates NEXIUM(R) Benefits Patients With Zollinger-Ellison Syndrome
HSMN NewsFeed - 22 May 2006
New Study Shows Erosive Esophagitis Healing Linked to Gastric Acid Control
New Study Shows Erosive Esophagitis Healing Linked to Gastric Acid Control
Additional items found! 76
Members Archive contains
76 additional stories matching:
proton pump inhibitor
(Password required)
proton pump inhibitor
(Password required)